Choose Vazculep, the only FDA-Approved Phenylephrine HCI Injection available in all 3 vial sizes – 1mL, 5mL and 10mL.

  • Manufactured in a cGMP facility with a commitment to have adequate inventory in order to ensure an uninterrupted supply of product
  • Available with all leading wholesalers

INDICATIONS AND USAGE

VAZCULEP® (phenylephrine hydrochloride) Injection is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Important Safety Information

CONTRAINDICATIONS

None

WARNINGS AND PRECAUTIONS

Extravasation during intravenous administration may cause necrosis or sloughing of tissue.
Severe bradycardia and decreased cardiac output.
Allergic-type reactions: Sulfite.
Concomitant use with oxytocic drugs: Pressor effect of sympathomimetic pressor amines is potentiated.

ADVERSE REACTIONS

Most common adverse reactions during treatment: nausea, vomiting, and headache.